SEC Form 4 · accession 0001104659-15-018210
Vitae Pharmaceuticals, Inc · VTAE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jeffrey S. Hatfield
Officer — Chief Executive Officer · Director
Period of report
Mar 6, 2015
Accepted (ET)
Mar 9, 2015 · 5:05 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001157602
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 6, 2015 | M | 8,115 | $1.15 | A | 438,516 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy)F1 | $1.15 | Mar 6, 2015 | M | 8,115 | D | — | Mar 14, 2015 | Common Stock | 8,115 | 0 | D |
Explanation of responses
- F1This option vested in substantially equal installments over 12 months of service following March 15, 2005.